23 results on '"Raychaudhuri, Deblina"'
Search Results
2. Immune checkpoint therapy—current perspectives and future directions
3. Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19
4. A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
5. Activity-guided development of potent and selective toll-like receptor 9 antagonists
6. Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade
7. Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19
8. Myeloid-specific KDM6B inhibition sensitizes Glioblastoma to PD1 blockade
9. Myeloid cell-targeted therapies for solid tumours
10. Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19.
11. Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19
12. Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9
13. A Chemical Switch for Transforming a Purine Agonist for Toll-like Receptor 7 to a Clinically Relevant Antagonist
14. Role of Ca2+ in toll-like receptor 9 activation in human plasmacytoid dendritic cells
15. Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells
16. Cutting Edge: Dysregulated Endocannabinoid-Rheostat for Plasmacytoid Dendritic Cell Activation in a Systemic Lupus Endophenotype
17. Cutting Edge: Piezo1 Mechanosensors Optimize Human T Cell Activation
18. Adipose Recruitment and Activation of Plasmacytoid Dendritic Cells Fuel Metaflammation
19. Cutting Edge: Piezo1 Mechanosensors Optimize Human T Cell Activation.
20. Activity-guided development of potent and selective toll-like receptor 9 antagonists.
21. Cutting Edge: ATP13A2 Is an Endolysosomal Regulator of TLR9/7 Activation in Human Plasmacytoid Dendritic Cells.
22. Histone Lactylation Drives CD8 T Cell Metabolism and Function.
23. Role of Ca 2+ in toll-like receptor 9 activation in human plasmacytoid dendritic cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.